Imho, Doing another share buy back is unlikely until they get another sec warning letter to comply. But by then do they have any money left to do another share buyback when that happens. Nora pharma rev is 10.7 million but net is only 335k. Meaning they spend all their money on overhead. And don’t forget we pay the three stooges decent salaries to do stuff whatever it is. Even if trials with another unnamed partnership starts in March, by now ppl don’t care anymore. Because the market don’t trust SBFM, retailers don’t trust SBFM, and institutions don’t trust SBFM.. unnamed partners and we anticipate no longer works.
News 
Market Data 
Discover 
